Table 3.
Items | Total | Male | Female | ||||||
---|---|---|---|---|---|---|---|---|---|
PNB | LIA | P value | PNB | LIA | P value | PNB | LIA | P value | |
Day 1 nausea | 0.07 | 0.59 | 0.16 | ||||||
Yes | 26 (32%) | 25 (20%) | 2 (17%) | 4 (11%) | 24 (34%) | 21 (25%) | |||
No | 56 (68%) | 99 (80%) | 10 (73%) | 33 (89%) | 46 (66%) | 66 (75%) | |||
Day 1 vomit | 0.08 | 0.43 | 0.31 | ||||||
Yes | 14 (18%) | 13 (10%) | 1 (8%) | 1 (3%) | 13 (20%) | 12 (14%) | |||
No | 64 (82%) | 111 (90%) | 12 (92%) | 36 (97%) | 52 (80%) | 75 (86%) | |||
Day 1 pruritus | 0.90 | 0.54 | 0.69 | ||||||
Yes | 2 (3%) | 3 (3%) | 0 (0%) | 1 (3%) | 2 (4%) | 2 (2%) | |||
No | 68 (97%) | 117 (97%) | 13 (100%) | 35 (97%) | 55 (96%) | 82 (98%) | |||
Day 1 sedation | 0.20 | 0.86 | 0.22 | ||||||
Yes | 10 (13%) | 9 (7%) | 1 (7%) | 2 (5%) | 9 (14%) | 7 (8%) | |||
No | 68 (87%) | 115 (93%) | 14 (93%) | 35 (95%) | 54 (86%) | 80 (92%) | |||
Day 2 nausea | 0.02 | 0.12 | 0.09 | ||||||
Yes | 21 (26%) | 16 (13%) | 3 (25%) | 3 (8%) | 18 (26%) | 13 (15%) | |||
No | 61 (74%) | 108 (87%) | 9 (75%) | 34 (92%) | 52 (74%) | 74 (75%) | |||
Day 2 vomit | 0.05 | 0.13 | 0.91 | ||||||
Yes | 6 (8%) | 12 (10%) | 2 (13%) | 2 (5%) | 4 (6%) | 10 (11%) | |||
No | 71 (92%) | 112 (90%) | 13 (87%) | 35 (95%) | 58 (74%) | 77 (89%) | |||
Day 2 pruritus | 0.77 | – | 0.85 | ||||||
Yes | 1 (1%) | 1 (0%) | 0 (0%) | 0 (0%) | 1 (2%) | 1 (1%) | |||
No | 69 (99%) | 105 (100%) | 13 (100%) | 35 (100%) | 56 (98%) | 73 (99%) | |||
Day 2 sedation | 0.20 | 0.85 | 0.10 | ||||||
Yes | 5 (6%) | 3 (3%) | 1 (7%) | 2 (6%) | 4 (6%) | 1 (1%) | |||
No | 72 (94%) | 111 (97%) | 13 (93%) | 33 (94%) | 58 (94%) | 78 (99%) |
Side effects on POD1and 2 including nausea, vomiting, urinary retention, pruritus, and sedation presented as number (%)
PNB peripheral nerve block, LIA local infiltration analgesia